FDA Inspection 931077 — Strides House Bilekahalti
The FDA completed an inspection of Strides House Bilekahalti on May 20, 2015 in Bangalore. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 20, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bangalore (India)
Additional details
Postmarket Adverse Drug Experience (PADE)